ArticleScientific reports2025

BRPF1 inhibition reduces migration and invasion of metastatic ovarian cancer cells, representing a potential therapeutic target.

Elena Alexandrova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.